Patent Application
Utility
PCT National Stage
App. No. 18/023,270
· Confirmation No. 6500
COMPOUNDS AND METHODS OF USE
Applicant:
Ferro Therapeutics, Inc
Non Final Action Mailed
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-03-04 | OA.POSTCARD |
A courtesy postcard sent by USPTO to users who opt-in for e-Office Action | 1 | View | |
| 2026-02-25 | CTNF |
Non-Final Rejection | 8 | View | |
| 2026-02-25 | EXIN |
Examiner Interview Summary Record (PTOL - 413) | 1 | View | |
| 2026-02-25 | 892 |
List of references cited by examiner | 1 | View | |
| 2026-02-25 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2026-02-25 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2026-02-25 | SRNT |
Examiner's search strategy and results | 4 | View | |
| 2026-02-25 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2026-02-25 | 1449 |
List of References cited by applicant and considered by examiner | 1 | View | |
| 2026-02-06 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2026-02-02 | ELC. |
Response to Election / Restriction Filed | 3 | View | |
| 2026-02-02 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2026-02-02 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 2 | View | |
| 2026-02-02 | PA.. |
Power of Attorney | 2 | View | |
| 2026-02-02 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 16 | View | |
| 2026-02-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-08-01 | CTRS |
Requirement for Restriction/Election | 10 | View | |
| 2025-08-01 | 892 |
List of references cited by examiner | 1 | View | |
| 2025-08-01 | FOR |
Foreign Reference | 404 | View | |
| 2024-06-20 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-06-20 | M903 |
Notice of Designated Office (DO) / Elected Office (EO) Acceptance Mailed | 2 | View | |
| 2024-06-20 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2024-06-20 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-04-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-04-19 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-04-19 | A.PE |
Preliminary Amendment | 1 | View | |
| 2024-04-19 | CLM |
Claims | 61 | View | |
| 2024-04-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2024-03-21 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2023-10-20 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2023-10-20 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2023-10-20 | 371.FEE.M923 |
371 (National Stage) Supplemental Fees Missing - Form M923 | 2 | View | |
| 2023-10-20 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-02-24 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2023-02-24 | FOR |
Foreign Reference | 193 | View | |
| 2023-02-24 | FOR |
Foreign Reference | 404 | View | |
| 2023-02-24 | FOR |
Foreign Reference | 213 | View | |
| 2023-02-24 | FOR |
Foreign Reference | 163 | View | |
| 2023-02-24 | FOR |
Foreign Reference | 327 | View | |
| 2023-02-24 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 14 | View | |
| 2023-02-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2023-02-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2023-02-24 | TRNA |
Transmittal of New Application | 4 | View | |
| 2023-02-24 | ADS |
Application Data Sheet | 7 | View | |
| 2023-02-24 | 371P |
Documents submitted with 371 (National Stage) Applications | 355 | View | |
| 2023-02-24 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2023-02-24 | A.PE |
Preliminary Amendment | 1 | View | |
| 2023-02-24 | SPEC |
Specification | 1 | View | |
| 2023-02-24 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2023-02-24 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 5 | View | |
| 2023-02-24 | FRPR |
Certified Copy of Foreign Priority Application | 176 | View | |
| 2023-02-24 | FRPR |
Certified Copy of Foreign Priority Application | 142 | View | |
| 2023-02-24 | ABST |
Abstract | 1 | View | |
| 2023-02-24 | CLM |
Claims | 49 | View | |
| 2023-02-24 | SPEC |
Specification | 305 | View |
Inventors
Chun Jiang
Hillsborough, CA
Bin Wang
Dallas, TX
Rui Xu
Dallas, TX
Eli Wallace
Loveland, CO
Chunhe Xie
Palo Alto, CA
Attorneys & Agents of Record
Classification
USPC
514/235.2
C07D217/14
A61P35/00
C07D401/10
C07D401/12
C07D471/04
C07D495/04
C07F7/081
Prosecution
- Examiner
- HEASLEY, MEGHAN CHRISTINE
- Art Unit
- 1626
- Customer No.
- 122516
- Docket No.
- KGF-10.831
- Confirmation No.
- 6500
Publication
- Pub. No.
- US20240092739A1
- Pub. Date
- 2024-03-21
Parent
PCT
is a National Stage Entry of
→
PCT/CN2021/114827
Filed 2021-08-26
· Non Final Action Mailed
Parent
Claims priority from a provisional application
→
App. 63/070,750
Filed 2020-08-26
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 63/070,757
Filed 2020-08-26
· Provisional Application Expired
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/023,270
- Filed
- 2023-02-24
- Pub. No.
- US20240092739A1
- Examiner
- HEASLEY, MEGHAN CHRISTINE
- Art Unit
- 1626
External Links